Palbace 75 mg Capsule
  1. Home
  2. Pharma Products
  3. Pfizer Ltd
  4. Palbace 75 mg Capsule

Palbace 75 mg Capsule

Palbace 75 mg Capsule contains palbociclib, a cyclin-dependent kinase 4/6 inhibitor used to treat certain advanced or metastatic breast cancers. It is indicated for hormone receptor-positive and HER2-negative breast cancer in combination with endocrine therapy. The capsule is taken orally under the supervision of a qualified healthcare professional.

BUY NOW

Category

Palbace 75 mg Capsule contains 75 mg of palbociclib and is supplied as an oral hard capsule. Palbociclib inhibits CDK4 and CDK6, helping slow the progression of cancer cells through the cell cycle. It is used with an aromatase inhibitor or fulvestrant according to the prescribed treatment plan. Regular blood-count monitoring is required because palbociclib can reduce blood cell levels during treatment.

Technical Specification

Specification Details
Active Ingredient Palbociclib 75 mg
Dosage Form Hard Capsule
Therapeutic Class Cyclin-Dependent Kinase Inhibitor
Main Indication HR-Positive, HER2-Negative Breast Cancer
Route of Administration Oral
Storage Below 30°C

Product Also Known As

Palbace 75 mg Capsule, Palbace 75 mg, Palbociclib 75 mg Capsule, Palbociclib 75 mg, Palbociclib Hard Capsule, Palbociclib Breast Cancer Capsule